Pharmacoepidemiologic study of potential drug interactions in outpatients of a university hospital in Thailand.

Abstract:

BACKGROUND:Drug-drug interaction is a potential cause of adverse drug reactions. The incidence of such drug interactions in university hospitals in Thailand is unknown. PURPOSE:To estimate the rate of potential drug-drug interactions in outpatients of a typical Thai university hospital, and to identify risk factors for such interactions in Thai patients. METHODS:One-year outpatients' prescription data were retrieved from the hospital computer records. Potential drug interactions were identified using the existing drug-interaction database system. Potential interactions within a specific prescription and involving drugs prescribed 1-, 3- and 7-day earlier were searched for. Possible associations between occurrence of an interaction and a patient's age and gender and the number of items on the prescription were explored. RESULTS:The overall rate of potential drug interactions was 27.9% with a maximal value of 57.8% at the Department of Psychiatry. The rate of the most potentially significant interactions was 2.6%, being the highest in the Department of Medicine (6.0%), with isoniazid vs. rifampin as the most common interacting combination. The rate increased with the patient's age and prescription size (P=0.000). The odd's ratio of having at least one potential drug interaction was 1.8 (64.2%) when age increased by 20 years (P=0.000) and 2.8 (165.7%) when another drug was added (P=0.000). The rate of potential drug interactions was the same for both genders. The rate of potential drug interactions detected across prescriptions was higher than within prescriptions and was dependent on the time interval between prescriptions. CONCLUSIONS:Potential drug interactions were common in our sample of patients. The rate of such interactions increased with the number of drugs prescribed and the patient's age.

journal_name

J Clin Pharm Ther

authors

Janchawee B,Wongpoowarak W,Owatranporn T,Chongsuvivatwong V

doi

10.1111/j.1365-2710.2004.00598.x

subject

Has Abstract

pub_date

2005-02-01 00:00:00

pages

13-20

issue

1

eissn

0269-4727

issn

1365-2710

pii

JCP598

journal_volume

30

pub_type

杂志文章
  • Piracetam in the treatment of schizophrenia: implications for the glutamate hypothesis of schizophrenia.

    abstract:OBJECTIVE:There is a growing interest in investigating the role of glutamate receptors in the pathophysiology of schizophrenia. Indeed, the hyperdopaminergic theory of schizophrenia can explain only the positive symptoms of schizophrenia, whereas the glutamate hypothesis may provide a more comprehensive view of the ill...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:10.1046/j.1365-2710.1999.00238.x

    authors: Noorbala AA,Akhondzadeh S,Davari-Ashtiani R,Amini-Nooshabadi H

    更新日期:1999-10-01 00:00:00

  • Multiple inductive effects of carbamazepine on combined therapy with paliperidone and amlodipine.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Carbamazepine is a potent inducer of cytochrome P450 3A and P-glycoprotein. However, there are no reports of the effects of carbamazepine on more than one co-administered drug. CASE SUMMARY:A 53-year-old female patient with schizophrenia and hypertension was on paliperidone 12 mg/day and am...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12286

    authors: Akamine Y,Uehara H,Miura M,Yasui-Furukori N,Uno T

    更新日期:2015-08-01 00:00:00

  • Evaluation of clinical pharmacist interventions on drug interactions in outpatient pharmaceutical HIV-care.

    abstract:OBJECTIVE:To evaluate the usefulness of intervention in drug interactions of antiretroviral drugs with coadministered agents by a clinical pharmacist in outpatient HIV-treatment. METHODS:The study design included two intervention arms (A and B), which were both preceded by a control observation period. In arm A, a com...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2003.00541.x

    authors: de Maat MM,de Boer A,Koks CH,Mulder JW,Meenhorst PL,van Gorp EC,Mairuhu AT,Huitema AD,Beijnen JH

    更新日期:2004-04-01 00:00:00

  • Population pharmacokinetics of levetiracetam in neonates with seizures.

    abstract:WHAT IS KNOWN AND OBJECTIVE:This study developed a population pharmacokinetic (PK) model of levetiracetam (LEV) for treating neonatal seizures (NS) and determined the influence of clinically relevant covariates to explain the interindividual variability and residual error. METHODS:Twenty newborns admitted to the Neona...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12658

    authors: Lima-Rogel V,López-López EJ,Medellín-Garibay SE,Gómez-Ruiz LM,Romero-Méndez C,Milán-Segovia RC,Romano-Moreno S

    更新日期:2018-06-01 00:00:00

  • Comparison of pharmacodynamic effects of ticagrelor vs prasugrel in type 2 diabetes mellitus patients with coronary heart disease.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Patients with type 2 diabetes mellitus (T2DM) are at higher risk of thrombotic complications. Studies have indicated that patients with T2DM have impaired clopidogrel-induced antiplatelet effect. Ticagrelor and prasugrel are two latest generation P2Y12 inhibitors with advantageous platelet i...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,随机对照试验

    doi:10.1111/jcpt.12651

    authors: Shang LL,Guo DD,Zhao HY,Quan AJ,Cao PG

    更新日期:2018-06-01 00:00:00

  • Hyponatraemia induced by terlipressin: a case report and literature review.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Terlipressin is widely used to treat variceal bleeding and hepatorenal syndrome. We report one case of stubborn hyponatraemia induced by long-term (up to 21 days) therapy with terlipressin and review the side effects of this agent. CASE SUMMARY:A 41-year-old man with variceal rebleeding exp...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/jcpt.12335

    authors: Huang Y,Wang M,Wang J

    更新日期:2015-12-01 00:00:00

  • Structure-activity relationship: analyses of p-glycoprotein substrates and inhibitors.

    abstract:OBJECTIVE:A large number of structurally and functionally diverse compounds act as substrates or modulators of p-glycoprotein (p-gp). Some of them possess multiple drug resistance (MDR)-reversing activity, but only a small number of them have entered clinical study. In order to uncover the factors which exert a signifi...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1046/j.1365-2710.2003.00487.x

    authors: Wang RB,Kuo CL,Lien LL,Lien EJ

    更新日期:2003-06-01 00:00:00

  • Genetic predisposition to atorvastatin-induced myopathy: a case report.

    abstract:WHAT IS KNOWN AND OBJECTIVE:The major clinical complication of statins is a variety of muscle complaints ranging from myalgia to rhabdomyolysis. There is growing evidence that carriers of genetic polymorphisms in the enzymes and transporters implicated in statin disposition, particularly the SLCO1B1 gene, are at increa...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2012.01337.x

    authors: Francesca Notarangelo M,Marziliano N,Antonietta Demola M,Pigazzani F,Guidorossi A,Angelica Merlini P,Ardissino D

    更新日期:2012-10-01 00:00:00

  • Factors limiting adherence to antiepileptic treatment: A French online patient survey.

    abstract:WHAT IS KNOWN AND OBJECTIVE:There are various reasons why antiepileptic treatment can fail. One is drug-resistant epilepsies, but non-adherence, or poor adherence, to treatment may make some patients' treatment ineffective. The consequences of poor adherence include treatment failure or introduction of more complex tre...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12615

    authors: Laville F,Montana M,Roux N,Rathelot P,Giorgi R,Vanelle P

    更新日期:2018-02-01 00:00:00

  • Evaluation of the trends and appropriateness of fluoroquinolone use in the outpatient treatment of acute uncomplicated cystitis at five family practice clinics.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Despite recommendations to avoid fluoroquinolones (FQs) as a first-line treatment for uncomplicated cystitis, recent data suggest that FQs remain widely prescribed. Therefore, the objectives of this study were to evaluate the appropriateness of empiric FQ use compared to nitrofurantoin for u...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.13099

    authors: Robinson TF,Barsoumian AE,Aden JK,Giancola SE

    更新日期:2020-06-01 00:00:00

  • Effect of the number of dose adjustment factors on bleeding risk in patients receiving 30 mg/day edoxaban.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Edoxaban has three dose adjustment factors (creatinine clearance, 15-50 mL/min; body weight, 60 kg or less; and concomitant medication with potent P-glycoprotein inhibitors) to prevent bleeding that results from elevated blood concentrations of the drug. A dose reduction (from 60 to 30 mg/da...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.13065

    authors: Takase T,Ikesue H,Nakagawa H,Kinoshita M,Muroi N,Kitai T,Furukawa Y,Hashida T

    更新日期:2020-04-01 00:00:00

  • Effects of vitamin E supplementation on glycaemic control in type 2 diabetes: systematic review of randomized controlled trials.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Lowering haemoglobin A(₁c) (HbA(₁c)) has clearly been shown to reduce microvascular complications of diabetes and possibly macrovascular disease and vitamin E has been suggested as a possibly useful intervention. Our aim is to evaluate the effect of vitamin E supplementation on glycaemic con...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,meta分析,评审

    doi:10.1111/j.1365-2710.2009.01154.x

    authors: Suksomboon N,Poolsup N,Sinprasert S

    更新日期:2011-02-01 00:00:00

  • Steroids in multiple sclerosis.

    abstract::Steroids are widely used in treating the relapse of multiple sclerosis. There is no place for long term steroid therapy of this disease. Current practice is a short course of high dose methylprednisolone which can be repeated after an interval, has proven safety and objectively accelerates recovery. ...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章,多中心研究,随机对照试验,评审

    doi:10.1111/j.1365-2710.1994.tb00677.x

    authors: Griffiths TD,Newman PK

    更新日期:1994-08-01 00:00:00

  • G-CSF for the prophylaxis of neutropenic fever in patients with small cell lung cancer receiving myelosuppressive antineoplastic chemotherapy: meta-analysis and pharmacoeconomic evaluation.

    abstract::Standard meta-analytical and pharmacoeconomic techniques were used to study the clinical effectiveness and the cost-effectiveness ratio of the prophylactic (or pre-emptive) administration of G-CSF to patients with small cell lung cancer treated with conventional myelosuppressive cytotoxic chemotherapy. In the first pa...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,meta分析

    doi:10.1111/j.1365-2710.1996.tb00001.x

    authors: Messori A,Trippoli S,Tendi E

    更新日期:1996-04-01 00:00:00

  • Hyperprolactinemia and amenorrhea associated with olanzapine normalized after addition of aripiprazole.

    abstract::Hyperprolactinemia is a frequent side-effect in the use of atypical antipsychotics. The propensity to induce hyperprolactinemia is highly substance dependent and hyperprolactinemia is not always associated with clinical side-effects. We report a case in which hyperprolactinemia and amenorrhea under the treatment with ...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2007.00806.x

    authors: Wolf J,Fiedler U

    更新日期:2007-04-01 00:00:00

  • QTc prolongation during antiviral therapy in two COVID-19 patients.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Acquired long QT syndrome secondary to drug-induced QT prolongation and torsades de pointes has been reported for antiviral drugs. However, no studies have reported an association between corrected QT (QTc) prolongation and antiviral therapy in patients with novel coronavirus disease (COVID-...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type:

    doi:10.1111/jcpt.13183

    authors: Zhu S,Wang J,Wang Y,Chu J,Liu Y,Chen X,Chen X

    更新日期:2020-10-01 00:00:00

  • Patterns of analgesic prescribing in a South African primary care setting.

    abstract::The primary aim of this study was to assess patterns of prescribing of analgesic medications in a primary care setting in South Africa. Medication records of 47,103 patients for the year 1995 were retrospectively reviewed. Analgesic agents represented 12.3% of the total number and 14.2% of the total cost of all the pr...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1046/j.1365-2710.1997.96175961.x

    authors: Truter I

    更新日期:1997-02-01 00:00:00

  • Compliance measure development and assessment of theophylline therapy in ambulatory patients.

    abstract::The objectives of this study were: (a) to develop a drug serum level-based compliance measure which incorporated pharmacokinetic analysis of patient and drug parameters and to compare it to refill records, an indirect measure, and (b) to use that measure to determine whether pharmacist consultation increased complianc...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: De Tullio PL,Kirking DM,Arslanian C,Olson DE

    更新日期:1987-02-01 00:00:00

  • Hepatotoxicity caused by mebendazole in a patient with Gilbert's syndrome.

    abstract:WHAT IS KNOWN AND OBJECTIVE:Mebendazole (MBZ) is a broad-spectrum antihelminthic agent of the benzimidazole type. Although MBZ has been reported to cause hepatic injury, case reports of severe hepatic injury are very rare. We report a case of severe hepatitis after administration of MBZ in a patient with Gilbert's synd...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type:

    doi:10.1111/jcpt.13033

    authors: Tolomeo M,Colomba C,Meli M,Cascio A

    更新日期:2019-12-01 00:00:00

  • Effect of delayed and/or missed enteric-coated divalproex doses on valproic acid concentrations: simulation and dose replacement recommendations for the clinician.

    abstract:BACKGROUND AND OBJECTIVE:Enteric-coated, delayed-release divalproex sodium requires multiple daily administrations and high adherence rate to prevent breakthrough seizures and control adverse effects. We evaluated the effect of missing one or two doses of divalproex for up to 24 h, followed by replacement and resumptio...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2006.00739.x

    authors: Dutta S,Reed RC

    更新日期:2006-08-01 00:00:00

  • Whole saliva and plasma levels of clozapine and desmethylclozapine.

    abstract:BACKGROUND:Therapeutic drug monitoring of clozapine as an aid in the treatment of schizophrenic states is commonly used in our hospital. OBJECTIVE:Development of a high-performance liquid chromatographic method for the determination of clozapine (CLZ) and its major metabolite desmethylclozapine (DMCLZ) in plasma and s...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章

    doi:10.1046/j.1365-2710.1998.00132.x

    authors: Dumortier G,Lochu A,Zerrouk A,Van Nieuwenhuyse V,Colen de Melo P,Roche Rabreau D,Degrassat K

    更新日期:1998-02-01 00:00:00

  • Paracetamol (acetaminophen) pack size restrictions and poisoning severity: time trends in enquiries to a UK poisons centre.

    abstract:BACKGROUND AND OBJECTIVE:In September 1998, legislation was introduced in the United Kingdom to limit paracetamol pack sizes to 16 tablets of 500 mg at general sales outlets and 32 tablets of 500 mg at pharmacies. The effect of the regulations on severity of paracetamol poisoning is unclear. The aim of this study was t...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2007.00842.x

    authors: Morgan O,Hawkins L,Edwards N,Dargan P

    更新日期:2007-10-01 00:00:00

  • Generic medicines: Greek physicians' perceptions and prescribing practices.

    abstract:BACKGROUND AND OBJECTIVE:The penetration of generic drugs in the Greek pharmaceutical market is placed among the weakest in the EU. The Greek regulatory framework does not systematically support the development of this subsector and physicians are not provided with incentives for prescribing generics. The aim of this s...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2009.01037.x

    authors: Tsiantou V,Zavras D,Kousoulakou H,Geitona M,Kyriopoulos J

    更新日期:2009-10-01 00:00:00

  • The quality of essential antimicrobial and antimalarial drugs marketed in Rwanda and Tanzania: influence of tropical storage conditions on in vitro dissolution.

    abstract:OBJECTIVE:The quality of 33 formulations of essential antimicrobial and antimalarial drugs (amoxicillin capsules, metronidazole tablets, sulfamethoxazole/trimethoprim tablets, quinine tablets and sulphadoxine/pyrimethamine tablets) marketed in Rwanda and Tanzania was assessed and the influence of tropical storage condi...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.2004.00568.x

    authors: Kayumba PC,Risha PG,Shewiyo D,Msami A,Masuki G,Ameye D,Vergote G,Ntawukuliryayo JD,Remon JP,Vervaet C

    更新日期:2004-08-01 00:00:00

  • Systematic review of the use of patients' own medications in acute care institutions.

    abstract:BACKGROUND:Patients' own medications (POM) are medications that patients have obtained in the community setting and bring to the hospital when admitted. The practice of using POMs has not been well studied. OBJECTIVE:To identify benefits, risks and other impacts on the use of POM in hospitals. METHODS:A systematic se...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1365-2710.2006.00773.x

    authors: Lummis H,Sketris I,Veldhuyzen van Zanten S

    更新日期:2006-12-01 00:00:00

  • Comparative analysis of the efficacy of omega-3 fatty acids for hypertriglyceridaemia management in Korea.

    abstract:WHAT IS KNOWN AND OBJECTIVE:This study aimed to compare the ability of statin monotherapy (ST group), omega-3 fatty acid monotherapy (OM_A group) and combination therapy with omega-3 fatty acids and a statin (OM_S group), to reduce triglyceride (TG) levels in patients with hypertriglyceridaemia. METHODS:In this retros...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/jcpt.12423

    authors: Kim HS,Kim H,Jeong YJ,Yang SJ,Baik SJ,Lee H,Lee SH,Cho JH,Choi IY,Yim HW,Yoon KH

    更新日期:2016-10-01 00:00:00

  • New medicines in primary care: a review of influences on general practitioner prescribing.

    abstract:BACKGROUND AND OBJECTIVE:The uptake of new medicines is slower in the UK than in many other countries. Previous research found that cost and price have little influence on general practitioner (GP) behaviour, but recent UK government policy may have heightened cost-consciousness. Focussing on new medicines, this review...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1365-2710.2008.00875.x

    authors: Mason A

    更新日期:2008-02-01 00:00:00

  • Echinacea intake induces an immune response through altered expression of leucocyte hsp70, increased white cell counts and improved erythrocyte antioxidant defences.

    abstract:OBJECTIVE:To study the effect of Echinacea tablets on the expression of leucocyte heat shock protein 70 (hsp70), erythrocyte haemolysis, plasma antioxidant status, serum chemistry, haematological values and plasma alkylamide concentrations. METHOD:Eleven healthy individuals (26-61 years of age) were evaluated at basel...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 临床试验,杂志文章

    doi:10.1111/j.1365-2710.2005.00658.x

    authors: Agnew LL,Guffogg SP,Matthias A,Lehmann RP,Bone KM,Watson K

    更新日期:2005-08-01 00:00:00

  • Comparison of single-point phenytoin dosage prediction techniques.

    abstract::To dose the anticonvulsant phenytoin (PHT) in a clinical situation is difficult because of the non-linear metabolism of the drug. Therefore many techniques have been advocated to aid dosage adjustments based on a single-point PHT concentration determined at steady-state (ss). We retrospectively investigated six method...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章

    doi:10.1111/j.1365-2710.1988.tb00196.x

    authors: Yukawa E,Higuchi S,Ohtsubo K,Aoyama T

    更新日期:1988-08-01 00:00:00

  • Phytotherapeutics: an evaluation of the potential of 1000 plants.

    abstract:OBJECTIVE:The aim of this review is to evaluate and summarize the available scientific information on the commonest plant extracts marketed in Western countries. In view of the intense, ongoing search for new plant extracts with powerful anti-inflammatory activity, we paid particular attention to this topic. The aim is...

    journal_title:Journal of clinical pharmacy and therapeutics

    pub_type: 杂志文章,评审

    doi:10.1111/j.1365-2710.2009.01096.x

    authors: Cravotto G,Boffa L,Genzini L,Garella D

    更新日期:2010-02-01 00:00:00